Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.

Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N.

PLoS One. 2011;6(5):e20470. doi: 10.1371/journal.pone.0020470. Epub 2011 May 27.

2.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

3.

Potential cytokine biomarkers in autism spectrum disorders.

Rose D, Ashwood P.

Biomark Med. 2014;8(9):1171-81. doi: 10.2217/bmm.14.39. Review.

PMID:
25402586
4.

Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder.

Napolioni V, Ober-Reynolds B, Szelinger S, Corneveaux JJ, Pawlowski T, Ober-Reynolds S, Kirwan J, Persico AM, Melmed RD, Craig DW, Smith CJ, Huentelman MJ.

J Neuroinflammation. 2013 Mar 14;10:38. doi: 10.1186/1742-2094-10-38.

5.
7.

Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.

Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, Van de Water J.

Biol Psychiatry. 2017 Mar 1;81(5):442-451. doi: 10.1016/j.biopsych.2015.08.007. Epub 2015 Aug 14.

8.

Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Goines PE, Ashwood P.

Neurotoxicol Teratol. 2013 Mar-Apr;36:67-81. doi: 10.1016/j.ntt.2012.07.006. Epub 2012 Aug 17. Review.

9.

Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation.

Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, DeLorenze GN, Kharrazi M, Yolken R, Ashwood P, Van de Water J.

Mol Psychiatry. 2017 Feb;22(2):273-279. doi: 10.1038/mp.2016.77. Epub 2016 May 24.

10.

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.

Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Croen LA.

J Neuroinflammation. 2014 Jun 20;11:113. doi: 10.1186/1742-2094-11-113.

11.

Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank.

Abdallah MW, Larsen N, Mortensen EL, Atladóttir HÓ, Nørgaard-Pedersen B, Bonefeld-Jørgensen EC, Grove J, Hougaard DM.

J Neuroimmunol. 2012 Nov 15;252(1-2):75-82. doi: 10.1016/j.jneuroim.2012.07.013. Epub 2012 Aug 20.

PMID:
22917523
12.

Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.

Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM.

World J Biol Psychiatry. 2013 Sep;14(7):528-38. doi: 10.3109/15622975.2011.639803. Epub 2011 Dec 19.

PMID:
22175527
13.

Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder.

Masi A, Breen EJ, Alvares GA, Glozier N, Hickie IB, Hunt A, Hui J, Beilby J, Ravine D, Wray J, Whitehouse AJO, Guastella AJ.

Mol Autism. 2017 Dec 2;8:63. doi: 10.1186/s13229-017-0176-2. eCollection 2017.

14.

Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study.

Barbosa IG, Rodrigues DH, Rocha NP, Sousa LF, Vieira EL, Simões-E-Silva AC, Kummer A, Teixeira AL.

J Neuroimmunol. 2015 Jan 15;278:69-72. doi: 10.1016/j.jneuroim.2014.11.021. Epub 2014 Nov 26.

PMID:
25595254
15.

Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Kano Y, Kasai K.

PLoS One. 2013 Sep 18;8(9):e73814. doi: 10.1371/journal.pone.0073814. eCollection 2013.

16.

Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.

J Neuroimmunol. 2011 Mar;232(1-2):196-9. doi: 10.1016/j.jneuroim.2010.10.025. Epub 2010 Nov 20.

17.

Altered T cell responses in children with autism.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.

Brain Behav Immun. 2011 Jul;25(5):840-9. doi: 10.1016/j.bbi.2010.09.002. Epub 2010 Sep 15.

18.

Altered cytokine and BDNF levels in autism spectrum disorder.

Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T.

Neurotox Res. 2013 Nov;24(4):491-501. doi: 10.1007/s12640-013-9393-4. Epub 2013 Apr 19.

PMID:
23604965
19.

Inflammatory Activity in Autism Spectrum Disorder.

Tonhajzerova I, Ondrejka I, Mestanik M, Mikolka P, Hrtanek I, Mestanikova A, Bujnakova I, Mokra D.

Adv Exp Med Biol. 2015;861:93-8. doi: 10.1007/5584_2015_145.

PMID:
26022900

Supplemental Content

Support Center